Biotechnology Stocks I Performance Guide: Keros Therapeutics, Inc. (KROS)
KROS has no dividends.
Table and Chart of KROS Performance
See what a $1,000 investment in KROS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KROS Returns | |
|---|---|
| Start Date | May-29-2020 |
| Start Price | $28.74 |
| End Date | May-07-2024 |
| End Price | $58.68 |
| # Prices | 49 |
| Min Date | Jun-30-2022 |
| Min Price | $27.63 |
| Max Date | Nov-30-2020 |
| Max Price | $75.61 |
| Total Return | 104.18% |
| Annualized Return | 19.10% |
| Current Value of $1,000 Purchase | $2,042 |
| Number Returns | 1,176 |
| Average Return | 5.60% |
| Number Profitable Returns | 555 |
| Percent Profitable Returns | 47.19% |
| Number Unprofitable Returns | 621 |
| Percent Unprofitable Returns | 52.81% |
| Profitable to Unprofitable Returns Ratio | 0.89 |
| KROS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,116,458,000 |
| Beta | 1.268 | Price to Sales | 13,966.49 |
| Earnings per Share | $-5.2000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.36 |
| PRICE DATA | |
| 52 Week High | $73 |
| 52 Week Low | $27.02 |
| Analyst Target Price | $88.88 |
| 50-Day Moving Average | $63.03 |
| 200-Day Moving Average | $44.92 |
| FINANCIAL DATA | |
| Revenue per Share | $0.005 |
| Revenue | $151,000 |
| Profit Margin | 0% |
| Return on Equity | -50.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KROS Compare Returns with S&P 500
KROS Trendline Chart
KROS Moving Average Chart
KROS Stock Return Map - See Patterns of Gains and Losses
KROS Stock Returns/Purchase Dates